Categories AlphaGraphs, Earnings, Technology

BB Earnings: A snapshot of BlackBerry’s Q4 2023 results

BlackBerry Limited (NYSE: BB) has reported a net loss for the fourth quarter of 2023 compared to a profit last year, as the tech firm’s revenues declined.

Total revenues decreased to $151 million in the fourth quarter from $185 million in the corresponding period of 2022. An increase in IoT revenues was more than offset by weakness in the other two operating segments.

Reflecting the weak top-line performance, the company reported a loss of $495 million or $0.85 per share for the February quarter, compared to a profit of $144 million in the prior-year period. Adjusted loss, on a per-share basis, was $0.02 per share, compared to earnings of $0.01 per share last year.

“As previously communicated, BlackBerry’s Cybersecurity business unit saw the timing of a number of large government deals slip into later quarters, but we are confident that they will close this fiscal year,” said John Chen, CEO of BlackBerry.

Prior Performance

  • BlackBerry Q3 2023 earnings infographic
  • BlackBerry Q2 2022 earnings infographic
  • Blackberry Q1 2023 earnings infographic
  • Expedia Q4 2021 earnings infographic

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top